Jingang Li1, Tamara Yawno1, Amy E Sutherland1, Shanti Gurung1, Madison Paton1, Courtney McDonald1, Abhilasha Tiwari1, Yen Pham1, Margie Castillo-Melendez1, Graham Jenkin2, Suzanne L Miller3. 1. The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia. 2. The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia. 3. The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia. Electronic address: suzie.miller@monash.edu.
Abstract
INTRODUCTION: Preterm infants are at high risk for white matter injury and subsequent neurodevelopmental impairments. Mesenchymal stem/stromal cells (MSC) have anti-inflammatory/immunomodulatory actions and are of interest for neural repair in adults and newborns. This study examined the neuroprotective effects of allogeneic MSC, derived from preterm umbilical cord blood (UCB), in a preterm sheep model of white matter injury. METHODS: Quad-lineage differentiation, clonogenicity and self-renewal ability of UCB-derived MSC were confirmed. Chronically instrumented fetal sheep (0.7 gestation) received either 25 min hypoxia-ischemia (HI) to induce preterm brain injury, or sham-HI. Ten million MSC, or saline, were administered iv to fetuses at 12 h after HI. Fetal brains were collected 10d after HI for histopathology and immunocytochemistry. RESULTS: HI induced white matter injury, as indicated by a reduction in CNPase-positive myelin fiber density. HI also induced microglial activation (Iba-1) in the periventricular white matter and internal capsule (P < .05 vs control). MSC administration following HI preserved myelination (P < .05), modified microglial activation, and promoted macrophage migration (CD163) and cell proliferation (Ki-67) within cerebral white matter (P < .05). Cerebral CXCL10 concentration was increased following MSC administration (P < .05), which was likely associated with macrophage migration and cell proliferation within the preterm brain. Additionally, MSC administration reduced systemic pro-inflammatory cytokine TNFα at 3d post-HI (P < .05). CONCLUSIONS: UCB-derived MSC therapy preserved white matter brain structure following preterm HI, mediated by a suppression of microglial activation, promotion of macrophage migration and acceleration of self-repair within the preterm brain. UCB-derived MSC are neuroprotective, acting via peripheral and cerebral anti-inflammatory and immunomodulatory mechanisms. Crown
INTRODUCTION: Preterm infants are at high risk for white matter injury and subsequent neurodevelopmental impairments. Mesenchymal stem/stromal cells (MSC) have anti-inflammatory/immunomodulatory actions and are of interest for neural repair in adults and newborns. This study examined the neuroprotective effects of allogeneic MSC, derived from preterm umbilical cord blood (UCB), in a preterm sheep model of white matter injury. METHODS: Quad-lineage differentiation, clonogenicity and self-renewal ability of UCB-derived MSC were confirmed. Chronically instrumented fetal sheep (0.7 gestation) received either 25 min hypoxia-ischemia (HI) to induce preterm brain injury, or sham-HI. Ten million MSC, or saline, were administered iv to fetuses at 12 h after HI. Fetal brains were collected 10d after HI for histopathology and immunocytochemistry. RESULTS:HI induced white matter injury, as indicated by a reduction in CNPase-positive myelin fiber density. HI also induced microglial activation (Iba-1) in the periventricular white matter and internal capsule (P < .05 vs control). MSC administration following HI preserved myelination (P < .05), modified microglial activation, and promoted macrophage migration (CD163) and cell proliferation (Ki-67) within cerebral white matter (P < .05). Cerebral CXCL10 concentration was increased following MSC administration (P < .05), which was likely associated with macrophage migration and cell proliferation within the preterm brain. Additionally, MSC administration reduced systemic pro-inflammatory cytokine TNFα at 3d post-HI (P < .05). CONCLUSIONS: UCB-derived MSC therapy preserved white matter brain structure following preterm HI, mediated by a suppression of microglial activation, promotion of macrophage migration and acceleration of self-repair within the preterm brain. UCB-derived MSC are neuroprotective, acting via peripheral and cerebral anti-inflammatory and immunomodulatory mechanisms. Crown
Authors: María F Zappa Villar; Juliette López Hanotte; Joaquín Pardo; Gustavo R Morel; Guillermo Mazzolini; Mariana G García; Paula C Reggiani Journal: Mol Neurobiol Date: 2019-08-10 Impact factor: 5.590
Authors: Tayla R Penny; Yen Pham; Amy E Sutherland; Joohyung Lee; Graham Jenkin; Michael C Fahey; Suzanne L Miller; Courtney A McDonald Journal: Sci Rep Date: 2021-08-04 Impact factor: 4.379
Authors: Beth J Allison; Hannah Youn; Atul Malhotra; Courtney A McDonald; Margie Castillo-Melendez; Yen Pham; Amy E Sutherland; Graham Jenkin; Graeme R Polglase; Suzanne L Miller Journal: Front Endocrinol (Lausanne) Date: 2020-03-03 Impact factor: 5.555
Authors: Daan R M G Ophelders; Ruth Gussenhoven; Luise Klein; Reint K Jellema; Rob J J Westerlaken; Matthias C Hütten; Jeroen Vermeulen; Guido Wassink; Alistair J Gunn; Tim G A M Wolfs Journal: Cells Date: 2020-08-10 Impact factor: 6.600
Authors: Nancy Farfán; Jaime Carril; Martina Redel; Marta Zamorano; Maureen Araya; Estephania Monzón; Raúl Alvarado; Norton Contreras; Andrea Tapia-Bustos; María Elena Quintanilla; Fernando Ezquer; José Luis Valdés; Yedy Israel; Mario Herrera-Marschitz; Paola Morales Journal: Int J Mol Sci Date: 2020-10-21 Impact factor: 5.923
Authors: Joanne O Davidson; Lotte G van den Heuij; Mhoyra Fraser; Guido Wassink; Suzanne L Miller; Rebecca Lim; Euan M Wallace; Graham Jenkin; Alistair J Gunn; Laura Bennet Journal: Stem Cells Transl Med Date: 2020-10-26 Impact factor: 6.940